AAAAAA
Results: 26-49/49
Authors:
John, LSS
Sauter, ER
Herlyn, M
Litwin, S
Adler-Storthz, K
Citation: Lss. John et al., Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53, CANC GENE T, 7(5), 2000, pp. 749-756
An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin
Authors:
Satyamoorthy, K
Oka, M
Herlyn, M
Citation: K. Satyamoorthy et al., An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin, PIGM CELL R, 13, 2000, pp. 87-93
Authors:
Fredericks, WJ
Ayyanathan, K
Herlyn, M
Friedman, JR
Rauscher, FJ
Citation: Wj. Fredericks et al., An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene, MOL CELL B, 20(14), 2000, pp. 5019-5031
Authors:
Oka, M
Berking, C
Nesbit, M
Satyamoorthy, K
Schaider, H
Murphy, G
Ichihashi, M
Sauter, E
Herlyn, M
Citation: M. Oka et al., Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers andleads to ulcer formation in human skin xenografts, LAB INV, 80(4), 2000, pp. 595-604
Authors:
Hsu, MY
Andl, T
Li, G
Meinkoth, JL
Herlyn, M
Citation: My. Hsu et al., Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression, J CELL SCI, 113(9), 2000, pp. 1535-1542
Authors:
Herlyn, M
Millat, G
Citation: M. Herlyn et G. Millat, Decline of the intertidal blue mussel (Mytilus edulis) stock at the coast of Lower Saxony (Wadden Sea) and influence of mussel fishery on the development of young mussel beds, HYDROBIOL, 426(1-3), 2000, pp. 203-210
Authors:
Ayyanathan, K
Fredericks, WJ
Berking, C
Herlyn, M
Balakrishnan, C
Gunther, E
Rauscher, FJ
Citation: K. Ayyanathan et al., Hormone-dependent tumor regression in vivo by an inducible transcriptionalrepressor directed at the PAX3-FKHR oncogene, CANCER RES, 60(20), 2000, pp. 5803-5814
Authors:
Hsu, MY
Meier, FE
Nesbit, M
Hsu, JY
Van Belle, P
Elder, DE
Herlyn, M
Citation: My. Hsu et al., E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors, AM J PATH, 156(5), 2000, pp. 1515-1525
Authors:
Meier, F
Nesbit, M
Hsu, MY
Martin, B
Van Belle, P
Elder, DE
Schaumburg-Lever, G
Garbe, C
Walz, TM
Donatien, P
Crombleholme, TM
Herlyn, M
Citation: F. Meier et al., Human melanoma progression in skin reconstructs - Biological significance of bFGF, AM J PATH, 156(1), 2000, pp. 193-200
Authors:
Herlyn, M
Citation: M. Herlyn, Endothelial cells as targets for tumor therapy, J IMMUNOTH, 22(3), 1999, pp. 185-185
Authors:
Sauter, ER
Nesbit, M
Watson, JC
Klein-Szanto, A
Litwin, S
Herlyn, M
Citation: Er. Sauter et al., Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck, CLIN CANC R, 5(4), 1999, pp. 775-782
Authors:
Hsu, JY
Hsu, MY
Sorger, T
Herlyn, M
Levine, EM
Citation: Jy. Hsu et al., Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulationof interleukin-1, IN VITRO-AN, 35(10), 1999, pp. 647-654
Authors:
Prabhu, NS
Somasundaram, K
Tian, H
Enders, GH
Satyamoorthy, K
Herlyn, M
El-Deiry, WS
Citation: Ns. Prabhu et al., The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity, INT J ONCOL, 15(2), 1999, pp. 209-216
Authors:
Nesbit, M
Nesbit, HKE
Bennett, J
Andl, T
Hsu, MY
Dejesus, E
McBrian, M
Gupta, AR
Eck, SL
Herlyn, M
Citation: M. Nesbit et al., Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes, ONCOGENE, 18(47), 1999, pp. 6469-6476
Authors:
Krasilnikov, M
Adler, V
Fuchs, SY
Dong, Z
Haimovitz-Friedman, A
Herlyn, M
Ronai, Z
Citation: M. Krasilnikov et al., Contribution of phosphatidylinositol 3-kinase to radiation resistance in human melanoma cells, MOL CARCINO, 24(1), 1999, pp. 64-69
Authors:
Mitra, J
Dai, CY
Somasundaram, K
El-Deiry, WS
Satyamoorthy, K
Herlyn, M
Enders, GH
Citation: J. Mitra et al., Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a), MOL CELL B, 19(5), 1999, pp. 3916-3928
Authors:
Satyamoorthy, K
Meier, F
Hsu, MY
Berking, C
Herlyn, M
Citation: K. Satyamoorthy et al., Human xenografts, human skin and skin reconstructs for studies in melanomadevelopment and progression, CANC METAST, 18(3), 1999, pp. 401-405
Authors:
Van Belle, PA
Elenitsas, R
Satyamoorthy, K
Wolfe, JT
Guerry, D
Schuchter, L
Van Belle, TJ
Albelda, S
Tahin, P
Herlyn, M
Elder, DE
Citation: Pa. Van Belle et al., Progression-related expression of beta 3 integrin in melanomas and nevi, HUMAN PATH, 30(5), 1999, pp. 562-567
Authors:
Ge, K
DuHadaway, J
Du, W
Herlyn, M
Rodeck, U
Prendergast, GC
Citation: K. Ge et al., Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma, P NAS US, 96(17), 1999, pp. 9689-9694
Authors:
Liechty, KW
Nesbit, M
Herlyn, M
Radu, A
Adzick, NS
Crombleholme, TM
Citation: Kw. Liechty et al., Adenoviral-mediated overexpression growth factor-B corrects ischemic of platelet-derived impaired wound healing, J INVES DER, 113(3), 1999, pp. 375-383
Authors:
Easty, DJ
Hill, SP
Hsu, MY
Fallowfield, ME
Florenes, VA
Herlyn, M
Bennett, DC
Citation: Dj. Easty et al., Up-regulation of ephrin-A1 during melanoma progression, INT J CANC, 84(5), 1999, pp. 494-501
Authors:
Moretti, S
Pinzi, C
Spallanzani, A
Berti, E
Chiarugi, A
Mazzoli, S
Fabiani, M
Vallecchi, C
Herlyn, M
Citation: S. Moretti et al., Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions, INT J CANC, 84(2), 1999, pp. 160-168
Authors:
Sauter, ER
Nesbit, M
Litwin, S
Klein-Szanto, AJP
Cheffetz, S
Herlyn, M
Citation: Er. Sauter et al., Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas, CANCER RES, 59(19), 1999, pp. 4876-4881
Authors:
Hsu, MY
Elder, DE
Herlyn, M
Citation: My. Hsu et al., Melanoma: The Wistar melanoma (WM) cell lines, HUM CEL CUL, 1, 1999, pp. 259-274